Pradaxa 110 mg/1
dabigatran etexilate mesylate · CAPSULE · Boehringer Ingelheim Pharmaceuticals Inc.
Pradaxa is a capsule containing dabigatran etexilate mesylate at 110 mg/1, taken oral. Manufactured by Boehringer Ingelheim Pharmaceuticals Inc..
Key Facts
- Brand Name
- Pradaxa
- Generic Name
- dabigatran etexilate mesylate
- NDC Code (Product)
0597-0108- Manufacturer
- Boehringer Ingelheim Pharmaceuticals Inc.
- Strength
- 110 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA022512
- Marketing Start
- 11/23/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is Pradaxa used for?
Pradaxa contains dabigatran etexilate mesylate. It is a capsule taken oral. Consult your doctor for specific uses.
Is Pradaxa a controlled substance?
Pradaxa is not classified as a controlled substance by the DEA.
What is the generic name for Pradaxa?
The generic name for Pradaxa is dabigatran etexilate mesylate. There are no other listed brand versions of dabigatran etexilate mesylate.
What is the NDC code for Pradaxa 110 mg/1?
The NDC (National Drug Code) for Pradaxa 110 mg/1 is 0597-0108, listed by Boehringer Ingelheim Pharmaceuticals Inc..
Other Pradaxa Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)